Blood pressure medication
Weak evidence
Clonidine (Catapres)
Older option with weak evidence. Rarely the right choice today.
30-second summary
Clonidine is a blood pressure medication that has been used off-label for hot flashes for decades. Its evidence is the weakest of the non-hormonal options — reducing hot flash frequency by approximately 20-40% compared to placebo. Side effects including dry mouth, dizziness, and constipation limit its usefulness. It is now rarely the right first choice when better options exist.
What it is
Originally developed as a blood pressure medication, clonidine works on receptors in the brain that are also involved in temperature regulation. It is one of the oldest non-hormonal treatments for hot flashes.
What the evidence shows
Modest reduction in hot flash frequency — smaller effect than SSRIs, SNRIs, or gabapentin. Inconsistent results across trials. Better than nothing but not by much for most women.
Honest about risks and side effects
Dry mouth, dizziness, constipation, and sedation are common. Blood pressure lowering effect can cause problems in women whose blood pressure is already normal or low. Withdrawal effects on stopping — must be tapered.
What we do not know
Optimal dose for menopausal hot flashes has not been established. Why some women respond better than others is not known.
Who it is best for
Women with high blood pressure who also need hot flash treatment — clonidine addresses both. Otherwise, almost always a third or fourth choice after HRT, SSRIs/SNRIs have been considered.
Who should be cautious
Women with normal or low blood pressure. Women on other blood pressure medications.
How to access this
Prescription required. Rarely the appropriate first recommendation — if this is offered without discussion of HRT and SSRIs, ask why those were not considered first.
Questions to ask your doctor
• Why clonidine specifically rather than an SSRI or HRT?
• Do I need to taper when stopping?
Rose honest take
"Clonidine is an older option that has largely been superseded by better alternatives. If it is being offered as a first-line treatment for hot flashes without discussion of HRT or SSRIs, ask why."